Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stem-Cell Cosmeceutical Firm NuGene Eyes Skin-Care Drug Approvals

Executive Summary

Acne treatments and burn-relief products based on human stem-cell media may be forthcoming from NuGene International, as newly created subsidiary NuGene BioPharma looks to parlay the firm’s existing technology into skin-care pharmaceuticals subject to FDA approval.

Advertisement

Related Content

NuGene Growing Its Stem-Cell Cosmeceuticals Biz; Regulatory Risks Noted
FDA Warning To L’Oreal Creates Uncertainty For Anti-Redness, Dark Spot Treatments
‘Revolution’ Quelled? FDA Warns Firm For ReLuma Stem-Cell Claims
Advertisement
UsernamePublicRestriction

Register

RS019403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel